Abstract
This study compares the clinical response to lofexidine and clonidine in the out-patient treatment of opiate withdrawal in 50 opiate addicts, using a randomised double-blind study design. Patients were taking 40 mg or less methadone daily, or equivalent amounts of other opiates. Fifty-eight percent of those starting treatment completed detoxification, and were opiate free at 4 weeks: more patients completed withdrawal in the lofexidine group, but the difference was not significant. Clonidine produced more hypotensive effects: more home visits were also required by medical staff. There was no other significant difference in side effects. Both drugs can be used successfully in out-patient detoxification, but lofexidine is more economical in regard to staff time.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic alpha-Agonists / adverse effects
-
Adrenergic alpha-Agonists / therapeutic use*
-
Adult
-
Ambulatory Care / methods
-
Blood Pressure / drug effects
-
Chi-Square Distribution
-
Clonidine / adverse effects
-
Clonidine / analogs & derivatives*
-
Clonidine / therapeutic use*
-
Double-Blind Method
-
Drug Therapy, Combination
-
Female
-
Humans
-
Male
-
Methadone / therapeutic use
-
Narcotic Antagonists / adverse effects
-
Narcotic Antagonists / therapeutic use*
-
Narcotics / therapeutic use
-
Opioid-Related Disorders / drug therapy*
-
Opioid-Related Disorders / rehabilitation
-
Severity of Illness Index
-
Substance Withdrawal Syndrome / drug therapy*
-
Time Factors
-
Treatment Outcome
Substances
-
Adrenergic alpha-Agonists
-
Narcotic Antagonists
-
Narcotics
-
Clonidine
-
Methadone
-
lofexidine